Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetylcysteine for SOS Prophylaxis in HSCT
NCT04712435Phase 2Unknown
- Sponsor
- IBCC Oncologia
- Start
- Apr 2021
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in sinusoidal obstruction syndrome (SOS), sponsored by IBCC Oncologia. Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
sinusoidal obstruction syndrome (SOS)
Beyond the preview
Go deeper on NCT04712435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04712435.